HemaCare Slows Losses After Cutting R&D; Costs

HemaCare Corp., a Sherman Oaks-based provider of blood products and services, reported a narrowed loss for the second quarter ending June 30.

The company reported a quarterly loss of $139,000, compared to a loss of $516,000 during the second quarter last year. The company said revenues for the second quarter of 1995 were down 11% to $2.55 million, compared to $2.87 million during the same period a year earlier.

For the six-month period, HemaCare posted a $187,000 loss, compared to a loss of $1.2 million during the same period in 1994. Revenues for the latest six months decreased slightly to $5.3 million, compared to $5.5 million during the first six months of 1994.

HemaCare said the narrowed loss came from the curtailment of research and development expenses.